Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis [Phase 3]

View source ↗

Summary

This clinical trial update notes a Phase 3 study evaluating fenofibrate combined with ursodeoxycholic acid in subjects with Primary Biliary Cholangitis, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)
  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cholangitis | Phase 3 | Status: RECRUITING